Others are faster growing ('aggressive'), for example, diffuse large B-cell lymphoma, Burkitt’s lymphoma and mantle cell lymphoma. Roche’s heritage in non-hodgkin lymphoma treatment Rituximab ...
In several B cell malignancies, BTK is a crucial mediator of oncogenic signalling pathways and inhibitors of this kinase have substantially improved patient outcomes. This Review discusses the ...